Video
Drug Induced Psoriasis.
IPC Jr. Councilor Deepak Balak defines drug-induced psoriasis, outlines its challenges, and highlights why these cases…
IPC Jr. Councilor Deepak Balak defines drug-induced psoriasis, outlines its challenges, and highlights why these cases…
Watch VideoThe 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
View ReportDr. Deepak Balak presents an overview of current value-based healthcare (VBHC) initiatives in dermatology, emphasizing…
Watch VideoDr. Willem Jan Bos highlights the significance of adopting value-based healthcare (#VBHC) to enhance efficiency,…
Watch VideoIPC GLOBAL WEBINAR SERIES Program chairs: Deepak Balak, Netherlands and Ricardo Romiti, Brazil Program faculty:…
Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The…
View ReportThe 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN) was held Wednesday, July 6 –…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.